Skip to main content
PMC home page
Thorax logoLink to Thorax
. 2003 Aug;58(8):726–728. doi: 10.1136/thorax.58.8.726

The pulmonary physician in critical care • Illustrative case 6: Acute chest syndrome of sickle cell anaemia

V Mak 1, S Davies 1
PMCID: PMC1746766  PMID: 12885995

Full Text

The Full Text of this article is available as a PDF (114.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adragna N. C., Fonseca P., Lauf P. K. Hydroxyurea affects cell morphology, cation transport, and red blood cell adhesion in cultured vascular endothelial cells. Blood. 1994 Jan 15;83(2):553–560. [PubMed] [Google Scholar]
  2. Aquino S. L., Gamsu G., Fahy J. V., Claster S., Embury S. H., Mentzer W. C., Vichinsky E. P. Chronic pulmonary disorders in sickle cell disease: findings at thin-section CT. Radiology. 1994 Dec;193(3):807–811. doi: 10.1148/radiology.193.3.7972829. [DOI] [PubMed] [Google Scholar]
  3. Atz A. M., Wessel D. L. Inhaled nitric oxide in sickle cell disease with acute chest syndrome. Anesthesiology. 1997 Oct;87(4):988–990. doi: 10.1097/00000542-199710000-00037. [DOI] [PubMed] [Google Scholar]
  4. Bellet P. S., Kalinyak K. A., Shukla R., Gelfand M. J., Rucknagel D. L. Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases. N Engl J Med. 1995 Sep 14;333(11):699–703. doi: 10.1056/NEJM199509143331104. [DOI] [PubMed] [Google Scholar]
  5. Castro O., Brambilla D. J., Thorington B., Reindorf C. A., Scott R. B., Gillette P., Vera J. C., Levy P. S. The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease. Blood. 1994 Jul 15;84(2):643–649. [PubMed] [Google Scholar]
  6. Charache S., Terrin M. L., Moore R. D., Dover G. J., Barton F. B., Eckert S. V., McMahon R. P., Bonds D. R. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med. 1995 May 18;332(20):1317–1322. doi: 10.1056/NEJM199505183322001. [DOI] [PubMed] [Google Scholar]
  7. Cranshaw J., Griffiths M. J. D., Evans T. W. The pulmonary physician in critical care - part 9: non-ventilatory strategies in ARDS. Thorax. 2002 Sep;57(9):823–829. doi: 10.1136/thorax.57.9.823. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Deem S., Swenson E. R., Alberts M. K., Hedges R. G., Bishop M. J. Red-blood-cell augmentation of hypoxic pulmonary vasoconstriction: hematocrit dependence and the importance of nitric oxide. Am J Respir Crit Care Med. 1998 Apr;157(4 Pt 1):1181–1186. doi: 10.1164/ajrccm.157.4.9707165. [DOI] [PubMed] [Google Scholar]
  9. Dweik R. A., Laskowski D., Abu-Soud H. M., Kaneko F., Hutte R., Stuehr D. J., Erzurum S. C. Nitric oxide synthesis in the lung. Regulation by oxygen through a kinetic mechanism. J Clin Invest. 1998 Feb 1;101(3):660–666. doi: 10.1172/JCI1378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Emre U., Miller S. T., Gutierez M., Steiner P., Rao S. P., Rao M. Effect of transfusion in acute chest syndrome of sickle cell disease. J Pediatr. 1995 Dec;127(6):901–904. doi: 10.1016/s0022-3476(95)70025-0. [DOI] [PubMed] [Google Scholar]
  11. Glover R. E., Ivy E. D., Orringer E. P., Maeda H., Mason R. P. Detection of nitrosyl hemoglobin in venous blood in the treatment of sickle cell anemia with hydroxyurea. Mol Pharmacol. 1999 Jun;55(6):1006–1010. doi: 10.1124/mol.55.6.1006. [DOI] [PubMed] [Google Scholar]
  12. Head C. A., Brugnara C., Martinez-Ruiz R., Kacmarek R. M., Bridges K. R., Kuter D., Bloch K. D., Zapol W. M. Low concentrations of nitric oxide increase oxygen affinity of sickle erythrocytes in vitro and in vivo. J Clin Invest. 1997 Sep 1;100(5):1193–1198. doi: 10.1172/JCI119631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. INGRAM V. M. Gene mutations in human haemoglobin: the chemical difference between normal and sickle cell haemoglobin. Nature. 1957 Aug 17;180(4581):326–328. doi: 10.1038/180326a0. [DOI] [PubMed] [Google Scholar]
  14. Moncada S., Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993 Dec 30;329(27):2002–2012. doi: 10.1056/NEJM199312303292706. [DOI] [PubMed] [Google Scholar]
  15. Pacelli R., Taira J., Cook J. A., Wink D. A., Krishna M. C. Hydroxyurea reacts with heme proteins to generate nitric oxide. Lancet. 1996 Mar 30;347(9005):900–900. doi: 10.1016/s0140-6736(96)91378-1. [DOI] [PubMed] [Google Scholar]
  16. Platt O. S., Brambilla D. J., Rosse W. F., Milner P. F., Castro O., Steinberg M. H., Klug P. P. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. 1994 Jun 9;330(23):1639–1644. doi: 10.1056/NEJM199406093302303. [DOI] [PubMed] [Google Scholar]
  17. Platt O. S., Orkin S. H., Dover G., Beardsley G. P., Miller B., Nathan D. G. Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia. J Clin Invest. 1984 Aug;74(2):652–656. doi: 10.1172/JCI111464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Platt O. S., Thorington B. D., Brambilla D. J., Milner P. F., Rosse W. F., Vichinsky E., Kinney T. R. Pain in sickle cell disease. Rates and risk factors. N Engl J Med. 1991 Jul 4;325(1):11–16. doi: 10.1056/NEJM199107043250103. [DOI] [PubMed] [Google Scholar]
  19. Rodgers G. P., Dover G. J., Noguchi C. T., Schechter A. N., Nienhuis A. W. Hematologic responses of patients with sickle cell disease to treatment with hydroxyurea. N Engl J Med. 1990 Apr 12;322(15):1037–1045. doi: 10.1056/NEJM199004123221504. [DOI] [PubMed] [Google Scholar]
  20. Setty B. N., Stuart M. J. Vascular cell adhesion molecule-1 is involved in mediating hypoxia-induced sickle red blood cell adherence to endothelium: potential role in sickle cell disease. Blood. 1996 Sep 15;88(6):2311–2320. [PubMed] [Google Scholar]
  21. Stuart M. J., Setty B. N. Sickle cell acute chest syndrome: pathogenesis and rationale for treatment. Blood. 1999 Sep 1;94(5):1555–1560. [PubMed] [Google Scholar]
  22. Styles L. A., Aarsman A. J., Vichinsky E. P., Kuypers F. A. Secretory phospholipase A(2) predicts impending acute chest syndrome in sickle cell disease. Blood. 2000 Nov 1;96(9):3276–3278. [PubMed] [Google Scholar]
  23. Styles L. A., Lubin B., Vichinsky E., Lawrence S., Hua M., Test S., Kuypers F. Decrease of very late activation antigen-4 and CD36 on reticulocytes in sickle cell patients treated with hydroxyurea. Blood. 1997 Apr 1;89(7):2554–2559. [PubMed] [Google Scholar]
  24. Styles L. A., Schalkwijk C. G., Aarsman A. J., Vichinsky E. P., Lubin B. H., Kuypers F. A. Phospholipase A2 levels in acute chest syndrome of sickle cell disease. Blood. 1996 Mar 15;87(6):2573–2578. [PubMed] [Google Scholar]
  25. Sullivan K. J., Goodwin S. R., Evangelist J., Moore R. D., Mehta P. Nitric oxide successfully used to treat acute chest syndrome of sickle cell disease in a young adolescent. Crit Care Med. 1999 Nov;27(11):2563–2568. doi: 10.1097/00003246-199911000-00039. [DOI] [PubMed] [Google Scholar]
  26. Vichinsky E. P., Neumayr L. D., Earles A. N., Williams R., Lennette E. T., Dean D., Nickerson B., Orringer E., McKie V., Bellevue R. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med. 2000 Jun 22;342(25):1855–1865. doi: 10.1056/NEJM200006223422502. [DOI] [PubMed] [Google Scholar]
  27. Vichinsky E. P., Styles L. A., Colangelo L. H., Wright E. C., Castro O., Nickerson B. Acute chest syndrome in sickle cell disease: clinical presentation and course. Cooperative Study of Sickle Cell Disease. Blood. 1997 Mar 1;89(5):1787–1792. [PubMed] [Google Scholar]
  28. Vichinsky E., Williams R., Das M., Earles A. N., Lewis N., Adler A., McQuitty J. Pulmonary fat embolism: a distinct cause of severe acute chest syndrome in sickle cell anemia. Blood. 1994 Jun 1;83(11):3107–3112. [PubMed] [Google Scholar]
  29. Wayne A. S., Kevy S. V., Nathan D. G. Transfusion management of sickle cell disease. Blood. 1993 Mar 1;81(5):1109–1123. [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES